A carregar...
Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes
INTRODUCTION: Abnormalities in lipid metabolism may contribute to the development and progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Fenofibrate induces early and reversible reduction in estimated glomerular filtration rate (eGFR), but it may have protective effects on...
Na minha lista:
| Publicado no: | Kidney Int Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308372/ https://ncbi.nlm.nih.gov/pubmed/30596172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.09.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|